Skip to main content
. Author manuscript; available in PMC: 2020 Jun 7.
Published in final edited form as: Am Soc Clin Oncol Educ Book. 2015:e50–e58. doi: 10.14694/EdBook_AM.2015.35.e50

FIGURE 1. Choice of Selective Estrogen Receptor Modulator or Aromatase Inhibitor for Breast Cancer Chemoprevention.

FIGURE 1.

Choice is based on menopausal status, history of thromboembolism, prior hysterectomy, and risk of osteoporosis (based upon the author’s personal algorithm and not a guideline recommendation).